Explained herein are pharmaceutical packaging units which reduce oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-sensitive medications, these devices such as a syringe with an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with extremely low permeability to oxygen and c